We are live on ! Find out more
EBS icon

Emergent Biosolutions
EBS

203 hedge funds and large institutions have $1.15B invested in Emergent Biosolutions in 2016 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 93 increasing their positions, 64 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

256% more call options, than puts

Call options by funds: $4.18M | Put options by funds: $1.17M

45% more repeat investments, than reductions

Existing positions increased: 93 | Existing positions reduced: 64

12% more capital invested

Capital invested by funds: $1.02B → $1.15B (+$124M)

1.11% less ownership

Funds ownership: 91.61% → 90.5% (-1.1%)

9% less funds holding

Funds holding: 224 → 203 (-21)

43% less first-time investments, than exits

New positions opened: 24 | Existing positions closed: 42

Holders
203
Holders Change
-21
Holders Change %
-9.38%
% of All Funds
5.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
93
Reduced
64
Closed
42
Calls
$4.18M
Puts
$1.17M
Net Calls
+$3M
Net Calls Change
+$11.9M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$13.8M
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$10.2M
3
GT
Glenmede Trust
Pennsylvania
+$10.1M
4
BFA
BlackRock Fund Advisors
California
+$8.29M
5
AAM
Aberdeen Asset Management
United Kingdom
+$7.87M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$17.7M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$8.98M
3
AL
AJO LP
Pennsylvania
-$8.97M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$8.65M
5
NI
Numeric Investors
Massachusetts
-$8.11M
Name Holding Trade Value Shares
Change 		Change in
Stake
SCA
76
Secor Capital Advisors
New York
$2.04M +$317K +10,906 +20%
SFM
77
Systematic Financial Management
New Jersey
$2.04M +$174K +5,980 +10%
Citadel Advisors
78
Citadel Advisors
Florida
$2.03M +$1.44M +49,493 +332%
CAM
79
ClariVest Asset Management
California
$2.01M -$804K -27,673 -30%
N
80
Nuveen
North Carolina
$1.96M +$92.7K +3,189 +5%
Comerica Bank
81
Comerica Bank
Texas
$1.93M +$105K +3,616 +6%
California Public Employees Retirement System
82
California Public Employees Retirement System
California
$1.85M -$494K -17,000 -22%
Swiss National Bank
83
Swiss National Bank
Switzerland
$1.75M -$105K -3,600 -6%
Bank of Montreal
84
Bank of Montreal
Ontario, Canada
$1.75M -$224K -7,718 -12%
TC
85
TFS Capital
Pennsylvania
$1.72M +$1.15M +39,567 +265%
RFC
86
Regions Financial Corp
Alabama
$1.7M +$262K +9,014 +20%
FIM
87
Freedom Investment Management
Connecticut
$1.63M -$248K -8,518 -14%
AA
88
ALPS Advisors
Colorado
$1.63M -$486K -16,730 -24%
NFA
89
Nationwide Fund Advisors
Ohio
$1.62M +$221K +7,600 +17%
CS
90
Credit Suisse
Switzerland
$1.59M -$27.9K -961 -2%
AllianceBernstein
91
AllianceBernstein
Tennessee
$1.56M -$386K -13,300 -21%
CIP
92
Convergence Investment Partners
Florida
$1.55M +$1.43M +49,167 New
Two Sigma Investments
93
Two Sigma Investments
New York
$1.54M -$2.79M -95,927 -66%
Asset Management One
94
Asset Management One
Japan
$1.49M – – –
RhumbLine Advisers
95
RhumbLine Advisers
Massachusetts
$1.47M +$121K +4,163 +10%
Canada Life
96
Canada Life
Manitoba, Canada
$1.46M +$146K +5,035 +12%
US Bancorp
97
US Bancorp
Minnesota
$1.42M +$361K +12,439 +38%
Nordea Investment Management
98
Nordea Investment Management
Sweden
$1.39M +$848K +29,193 +198%
Thrivent Financial for Lutherans
99
Thrivent Financial for Lutherans
Minnesota
$1.23M +$693K +23,850 +157%
Nisa Investment Advisors
100
Nisa Investment Advisors
Missouri
$1.17M +$416K +14,300 +62%
2 3
4
5 6

EBS Hedge Fund Activity: Q3 2016 in Review

203 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Emergent Biosolutions (EBS) for Q3 2016, worth a combined $1.15B — up 12% from $1.02B a quarter earlier.

Sellers outnumbered buyers: 42 funds closed out of EBS and 24 opened new positions — a net loss of 18 holders — while 64 trimmed existing stakes and 93 added.

The largest buyer was State Street, adding an estimated $13.8M. The largest seller was Morgan Stanley, cutting an estimated $17.7M.

  • 203 institutional investors held Emergent Biosolutions (EBS) as of Q3 2016, down from 224 in Q2 2016.
  • Funds reported $1.15B of Emergent Biosolutions stock for Q3 2016, up 12% quarter-over-quarter.
  • 24 funds opened new Emergent Biosolutions positions in Q3 2016 and 42 closed out, a net change of -18 holders.
  • The largest Emergent Biosolutions buyer in Q3 2016 was State Street, an estimated $13.8M added.
  • The largest Emergent Biosolutions seller in Q3 2016 was Morgan Stanley, an estimated $17.7M sold.

Based on aggregated 13F filings for Q3 2016.